TY - GEN AU - Alvarez, Rocio AU - Lopez Cortes, Luis E AU - Molina, Jose AU - Cisneros, Jose M AU - Pachon, Jeronimo PY - 2016 DO - 10.1128/AAC.03147-14 UR - http://hdl.handle.net/10668/9819 T2 - Antimicrobial agents and chemotherapy AB - The increasing number of infections produced by beta-lactam-resistant Gram-positive bacteria and the morbidity secondary to these infections make it necessary to optimize the use of vancomycin. In 2009, the American Society of Health-System... LA - en PB - American Society for Microbiology KW - Beta-lactam-resistant bacteria KW - Vancomycin dosage KW - Pharmacokinetics KW - Serum concentration monitoring KW - Nephrotoxicity KW - Renal replacement therapy KW - Anti-Bacterial Agents KW - Drug Administration Schedule KW - Humans KW - Microbial Sensitivity Tests KW - Staphylococcus aureus KW - Vancomycin TI - Optimizing the Clinical Use of Vancomycin. TY - review VL - 60 ER -